Mevociclib( SY-1365 )

Catalog No. M26471 CAS No. 1816989-16-8

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Mevociclib
Note

Research use only, not for human use.
Brief Description

Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.
Description

Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.
In Vitro

——
In Vivo

Animal Model:Mice, HCC70 xenograft model Dosage:20 mg/kg Administration:Intravenous injection, twice weekly, for 35 days Result:Inhibited tumor volume in vivo.
Synonyms

SY-1365
Pathway

Angiogenesis
Target

CDK
Recptor

Akt| caspase-3| JNK1| p44/42 MAPK| RhoGDI
Research Area

——
Indication

——

CAS Number

1816989-16-8
Formula Weight

587.13
Molecular Formula

C31H35ClN8O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 125 mg/mL (212.90 mM)
SMILES

CN(C)C\C=C\C(=O)Nc1ccc(nc1)C(=O)N[C@@]1(C)CCC[C@H](C1)Nc1ncc(Cl)c(n1)-c1c[nH]c2ccccc12
Chemical Name

——

1.Kohno K, Ohashi E, et al. Anti-inflammatory effects of adenosine N1-oxide. J Inflamm (Lond). 2015 Jan 20;12(1):2.

Calculator

molnova catalog